5-fluorouracil versus CCNU in the treatment of metastatic prostatic cancer.
D004341:Drug Evaluation; D005472:Fluorouracil / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007970:Leukopenia / Q000139:chemically induced; D008130:Lomustine / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D009362:Neoplasm Metastasis; D009607:Nitrosourea Compounds / Q000627:therapeutic use*; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D013921:Thrombocytopenia / Q000139:chemically induced
D009607:Nitrosourea Compounds; D008130:Lomustine; D005472:Fluorouracil